about
Tests to assist in the diagnosis of cutaneous melanoma in adults: a generic protocolNew diagnostic aids for melanomaPoint of care cutaneous imaging technology in melanoma screening and mole mappingSKINOMICS: Transcriptional Profiling in Dermatology and Skin BiologyDiagnostic and prognostic biomarkers in melanoma.Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safetyMelanoma genotypes and phenotypes get personal.Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design[Strategies for the noninvasive diagnosis of melanoma].Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents.Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.New diagnostics for melanoma detection: from artificial intelligence to RNA microarrays.The diagnostic evaluation of MelaFind multi-spectral objective computer vision system.Skinomics: past, present and future for diagnostic microarray studies in dermatology.Uses of non-invasive imaging in the diagnosis of skin cancer: an overview of the currently available modalities.Development of a curriculum in molecular diagnostics, genomics and personalized medicine for dermatology trainees.Microarray Analysis of Differentially-Expressed Genes Encoding CYP450 and Phase II Drug Metabolizing Enzymes in Psoriasis and Melanoma.Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions.Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma.Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.Noninvasive proteome analysis of psoriatic stratum corneum reflects pathophysiological pathways and is useful for drug profiling.Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.
P2860
Q24186719-2EDBBC97-C079-4385-B8E1-A6FFC78A239AQ27000654-E87E385E-66FF-4D89-B552-F5FC23B80CC8Q27006587-80AF824D-1B2B-4D89-A5C9-3C5ED5920AFFQ28728961-2A4A09C4-1AF9-4010-BB90-95242769535DQ33862470-54ED8EAA-1F5F-4F8E-8BA2-92CC7D9EBF28Q34639321-B52D5D58-3D15-4D11-9363-ABD8D81A4152Q34788817-FC7F70B7-4F0A-42E8-A7C3-CE20322D89D4Q35795835-C702B0E8-DD8F-457B-9A97-53A1AE7B176EQ36021565-E76E940A-8011-4CDA-B9E8-55C0D1A46236Q36414907-5D702BFB-8144-488B-8853-77F95C3E012AQ37886997-8EE26545-BD5D-4932-B3C2-6EC64CBE1051Q38029364-F0A32DD1-A104-4BDF-B062-DC0B2BE16A8BQ38094279-8237E384-7C72-42A6-AE19-0D845B4721E5Q38154933-5A99386B-37F0-4682-85FD-8CA27B4D2DBAQ38164826-5CB48E57-796A-4195-883F-DA5C93874676Q38872266-09B26FA1-F8D0-47F7-B3C0-069D2D55EDEAQ39582357-7C8F69B7-6E05-42D7-9F02-98C0D9C65A5CQ41066052-A84F7416-30AD-47B0-896A-8DFF967D1FDCQ44293088-6051D4C2-8085-4D01-822B-24795B7AFE20Q47197940-BB9A743A-28BA-4ABA-A31E-777440E820DEQ50953528-A7E2D798-AC29-4E10-8187-7C9013FF86E1Q51165648-14E01A77-0F5B-46E2-9089-52732C54BE8AQ51760444-F95CEA30-8857-419E-8BE5-C534CE2BBC47
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Noninvasive genomic detection of melanoma.
@ast
Noninvasive genomic detection of melanoma.
@en
type
label
Noninvasive genomic detection of melanoma.
@ast
Noninvasive genomic detection of melanoma.
@en
prefLabel
Noninvasive genomic detection of melanoma.
@ast
Noninvasive genomic detection of melanoma.
@en
P2093
P2860
P1476
Noninvasive genomic detection of melanoma.
@en
P2093
H Rabinovitz
R Scheinberg
P2860
P304
P356
10.1111/J.1365-2133.2011.10239.X
P407
P577
2011-03-25T00:00:00Z